Bioinformatic analysis of drug targets for triple-negative breast cancer

Bioinformatic analysis of drug targets for triple-negative breast cancer

Bibliographic Details
Main Authors:	Xiao-Wei Li, Chun-Bo Kang, Xiao-Qian Chi, Tie-Jun Liu
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Series:	Asian Journal of Surgery
Subjects:	Triple-negative breast cancer PI3K Bioinformatics FGFR3
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958422012027

Similar Items

Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer
by: Jeremy Johnson, et al.
Published: (2020-05-01)

Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders
by: Po-Han Lin, et al.
Published: (2022-12-01)

In Vitro and In Vivo Anti-Cancer Activity of Lasiokaurin in a Triple-Negative Breast Cancer Model
by: Jinrong Lin, et al.
Published: (2023-11-01)

Dysregulated Gab1 signalling in triple negative breast cancer
by: Hannes Bongartz, et al.
Published: (2024-03-01)

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
by: Xuemei Xie, et al.
Published: (2023-02-01)

Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer
by: Mirjana Prvanović, et al.
Published: (2021-11-01)

Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models
by: Zhanfang Guo, et al.
Published: (2020-12-01)

Approach to the Triple Negative Breast Cancer in New Drugs Area
by: Mehrzad Mirzania
Published: (2016-04-01)

Pimavanserin tartrate induces apoptosis and cytoprotective autophagy and synergizes with chemotherapy on triple negative breast cancer
by: Yiqian Zhang, et al.
Published: (2023-12-01)

Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer
by: Zhang Z, et al.
Published: (2023-09-01)

High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer
by: Sandra Torres-Ruiz, et al.
Published: (2023-02-01)

Identification of Key Prognostic Genes of Triple Negative Breast Cancer by LASSO-Based Machine Learning and Bioinformatics Analysis
by: De-Lun Chen, et al.
Published: (2022-05-01)

Identification of a Resistance Mechanism to IGF-IR Targeting in Human Triple Negative MDA-MB-231 Breast Cancer Cells
by: Jennifer Tsui, et al.
Published: (2021-04-01)

Immunomodulatory Properties of PI3K/AKT/mTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer
by: Zhizhu Zhang, et al.
Published: (2022-07-01)

Can MRI Biomarkers Predict Triple-Negative Breast Cancer?
by: Giuliana Moffa, et al.
Published: (2020-12-01)

Research Progress on Immunization and Targeted Therapy for Triple-negative Breast Cancer
by: SHI Chao, et al.
Published: (2023-07-01)

Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer
by: Xiuming Zhai, et al.
Published: (2020-09-01)

Retracted: Protective effect of hsa‐miR‐570‐3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway
by: Li‐Li Wang, et al.
Published: (2020-08-01)

The role of IMP3 immunohistochemistry expression in triple-negative breast cancer as a prognostic factor
by: K Kamala, et al.
Published: (2024-01-01)

Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer
by: Jakub Wesolowski, et al.
Published: (2022-08-01)

Tribbles Homolog 3 Involved in Radiation Response of Triple Negative Breast Cancer Cells by Regulating Notch1 Activation
by: Yueh-Chun Lee, et al.
Published: (2019-01-01)

Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer
by: Tomasz Powrózek, et al.
Published: (2022-02-01)

Eugenol-Induced Autophagy and Apoptosis in Breast Cancer Cells via PI3K/AKT/FOXO3a Pathway Inhibition
by: Mashan L. Abdullah, et al.
Published: (2021-08-01)

HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer
by: Behzad Mansoori, et al.
Published: (2021-10-01)

The therapeutic and prognostic role of cuproptosis-related genes in triple negative breast cancer
by: Bingye Shi, et al.
Published: (2023-05-01)

PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative
by: Liliana Ascione, et al.
Published: (2022-10-01)

Platinum chemotherapy for early triple-negative breast cancer
by: Sofia RE. Mason, et al.
Published: (2024-06-01)

Gallic acid suppresses the progression of triple-negative breast cancer HCC1806 cells via modulating PI3K/AKT/EGFR and MAPK signaling pathways
by: Si Lin, et al.
Published: (2022-11-01)

Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
by: Srijan Basu, et al.
Published: (2023-11-01)

Bioinformatics analysis and clinical significance of NRP-1 in triple-negative breast cancer
by: Xiao Ma, et al.
Published: (2024-03-01)

Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer
by: Huang Y, et al.
Published: (2023-07-01)

Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021-08-01)

Transcriptomics and Proteomics Characterizing the Anticancer Mechanisms of Natural Rebeccamycin Analog Loonamycin in Breast Cancer Cells
by: Xiao Sun, et al.
Published: (2022-10-01)

Response to cisplatin in a metastatic triple-negative breast cancer patient
by: Budhi Singh Yadav, et al.
Published: (2021-01-01)

3D printed model for triple negative inflammatory breast cancer
by: Yu-Hui Huang, et al.
Published: (2022-11-01)

Local Treatment of Triple-Negative Breast Cancer: Is Mastectomy Superior to Breast-Conserving Surgery?
by: Alba Di Leone, et al.
Published: (2023-05-01)

Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis
by: Canling Lin, et al.
Published: (2022-10-01)

Presentation and treatment of aggressive, Triple‐Negative carcinosarcoma of the breast
by: Niels Vizgan, et al.
Published: (2022-07-01)

SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways
by: Ariana Acevedo-Díaz, et al.
Published: (2022-06-01)

SEPTIN3 Promotes Progression of Triple-Negative Breast Cancer via Activating Wnt Pathway
by: Wang GZ, et al.
Published: (2023-09-01)